Pro-Dex Inc (PDEX, Financial) files its latest 10-K with SEC for the fiscal year ended on June 30, 2018. Pro-Dex Inc is engaged in designing, development and manufacturing of powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. Pro-Dex Inc has a market cap of $44.180 million; its shares were traded at around $10.20 with a P/E ratio of 26.83 and P/S ratio of 1.99.
For the last quarter Pro-Dex Inc reported a revenue of $6.25 million, compared with the revenue of $5.60 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $22.5 million, an increase of 2.4% from last year. For the last five years Pro-Dex Inc had an average revenue growth rate of 17.1% a year.
The reported diluted earnings per share was 37 cents for the year, a decline of 70.4% from the previous year. The Pro-Dex Inc had a decent operating margin of 15.16%, compared with the operating margin of 12.97% a year before. The 10-year historical median operating margin of Pro-Dex Inc is 1.45%. The profitability rank of the company is 7 (out of 10).
At the end of the fiscal year, Pro-Dex Inc has the cash and cash equivalents of $5.19 million, compared with $4.21 million in the previous year. The long term debt was $0.01 million, compared with $0.06 million in the previous year. The interest coverage to the debt is at a comfortable level of 486.4. Pro-Dex Inc has a financial strength rank of 9 (out of 10).
At the current stock price of $10.20, Pro-Dex Inc is traded at 240% premium to its historical median P/S valuation band of $3.00. The P/S ratio of the stock is 1.99, while the historical median P/S ratio is 0.58. The stock gained 30.26% during the past 12 months.
For the complete 20-year historical financial data of PDEX, click here.
